Heather Cox Richardson | Letters from an American | April 9
April 9, 2021
The 1918 influenza pandemic killed at least 50 million people across the world, including about 675,000 people in the United States. And yet, until recently, it has been elusive in our popular memory. America’s curious amnesia about the 1918 pandemic has come to mind lately as the United States appears to be shifting into a post-pandemic era of job growth and optimism.
A year ago today, I noted that we were approaching 17,000 deaths from Covid-19. Now our official death count is over 560,000. If anyone had told us a year ago that we would lose more than a half million of our family and friends to this pandemic, that number would have seemed unthinkable. And yet now, as more shots go into arms every day, attention to the extraordinary toll of the past year seems to be slipping.
Remembering the nation’s suffering under the pandemic matters because the contrast between the disastrous last year and our hope this spring is a snapshot of what is at stake in the fight over control of the nation’s government.
Ever since President Ronald Reagan declared in his 1981 inaugural address that “government is not the solution to our problem; government is the problem,” Republicans have argued that the best way to run the country has been to dismantle the federal government and turn the fundamental operations of the country over to private enterprise. They have argued that the government is inefficient and wasteful, while businesses can pivot rapidly and are far more efficient than their government counterparts.
The emergency authorization, before the U.S. and the E.U., paves the way for mass inoculations. As hospitalizations and infections surge across the U.S., California officials warn of severe shortages of beds and staff. [ . . . ]
As scientists at the Jenner Institute prepare for mass clinical trials, new tests show their vaccine to be effective in monkeys.
In the worldwide race for a vaccine to stop the coronavirus, the laboratory sprinting fastest is at Oxford University.
Most other teams have had to start with small clinical trials of a few hundred participants to demonstrate safety. But scientists at the university’s Jenner Institute had a head start on a vaccine, having proved in previous trials that similar inoculations — including one last year against an earlier coronavirus — were harmless to humans.
That has enabled them to leap ahead and schedule tests of their new coronavirus vaccine involving more than 6,000 people by the end of next month, hoping to show not only that it is safe, but also that it works.
The Oxford scientists now say that with an emergency approval from regulators, the first few million doses of their vaccine could be available by September — at least several months ahead of any of the other announced efforts — if it proves to be effective.
Now, they have received promising news suggesting that it might.
Scientists at the National Institutes of Health’s Rocky Mountain Laboratory in Montana last month inoculated six rhesus macaque monkeys with single doses of the Oxford vaccine. The animals were then exposed to heavy quantities of the virus that is causing the pandemic — exposure that had consistently sickened other monkeys in the lab. But more than 28 days later all six were healthy, said Vincent Munster, the researcher who conducted the test.